Products & Services

Gene Editing Services

Our proprietary CRISPR/Cas9-based gene-editing technology enhances editing efficiency by 10- to 20-fold, accelerating custom model development and making the process more cost-effective for your research.
Gene editing services assist researchers in studying gene function and associating specific genes with physiological and pathological phenotypes. These services are also widely used to generate animal models of disease, which facilitate the development of novel therapies. CRISPR/Cas9-based gene editing enables the creation of humanized animal models, which are extensively applied in disease research, drug screening, organ transplantation, diagnostics, and personalized medicine—particularly in the field of oncology.
  • 5,300+
    PROJECTS DELIVERED
  • 1,200+
    PUBLICATIONS BY CLIENTS
  • 2,500+
    clients worldwide

on this page

  • Why Biocytogen? – Global Experts in Gene Editing Services
  • Explore Our Technology Platforms and Gene-Targeting Strategies
  • Gene Editing by Strategies
  • Gene Editing by Technology
  • Frequently Asked Questions (FAQs)

Publication

    Why Biocytogen? – Global Experts in Gene Editing Services
    Over the past decade, Biocytogen has evolved into a global leader in gene editing services and animal model generation. Our cutting-edge technology platforms have enabled the creation of an extensive collection of humanized mouse models for research, drug screening, and therapeutic evaluation, as well as custom in vitro and in vivo models.
    Each year, we generate approximately 800 new in vivo models, including human gene knock in mouse strains. Biocytogen is committed to providing premier-quality products, outstanding technical support, and rapid turnaround times to advance your scientific goals. We apply rigorous quality control measures to ensure consistency and reliability. Connect with our experts to explore how Biocytogen's gene-editing expertise and custom animal model solutions can drive your preclinical research success.
    Explore Our Technology Platforms and Gene-Targeting Strategies
    Based on your specific project goals, our expert scientists will collaborate with you to identify the optimal gene-editing technologies for generating disease animal models, humanized mouse models, or custom knock-in mouse and knockout mouse lines. Because each project differs in success rate requirements, timelines, and resource allocation, please consult with our team for a specialized experimental design best suited to your scientific and translational research needs.
    Gene Editing by Strategies

    Biocytogen's professional technology team and sales staff strive to help researchers achieve their animal model needs. The gene targeting strategies that our customized models use include:

    Global Knockout (KO)

    In a global knockout (KO) mouse model, an exon of a target gene is globally deleted (EGE™ method) or replaced (ESC/HR) with a positive selection marker (Neomycin in most cases), thus inactivating the gene. In a global, or whole-body KO mice, the gene of interest in disrupted in every tissue.

    Global Knockout (KO)
    Global Knockin (KI)

    Global knockin mouse models introduce mutant or exogenous DNA sequences into a specific locus in the mouse genome. These models can mimic genetic diseases when mutation(s) are introduced, or monitor gene expression when genes are tagged with various proteins (e.g. EGFP, mRFP, mCherry, YFP, LacZ, and Flag).

    Global Knockin (KI)
    Conditional Knockout (cKO)

    A conditional knockout (cKO) model is generated via Cre-LoxP/Flp-Frt recombination systems. The targeted fragment to be knocked out is flanked by LoxP (or Frt) elements. Floxed mice are then bred with tissue-specific Cre mice or Flp mice—so that sequences between the LoxP sites will be removed from the offspring's genome in a tissue-specific pattern. In typical designs, a Cre mouse drives recombination only in the target tissue. LoxP fragments are commonly inserted into the introns downstream of the ATG-containing exon, and removal of the flanked exon(s) will result in a frame-shift that disrupts protein expression.

    Conditional Knockout (cKO)
    Conditional Knockin (cKI) Using the Cre Mouse System

    A conditional knockin (cKI) mouse model enables tissue-specific activation of exogenous genetic elements—such as point mutations, reporters, or functional cassettes—by crossing mice carrying a floxed allele with a tissue-specific or inducible Cre or CreERT2 mouse, ensuring activation only where Cre recombinase is present. These models are typically generated using the FLEx (Flip-Excision/dual-lox) system or a minigene-based design, allowing the engineered mutation or reporter to be expressed in a spatially and/or temporally controlled manner. This Cre-lox–driven cKI strategy is widely used to study gene regulation, perform lineage tracing, and dissect cell-type-specific biological functions.

    Conditional Knockin (cKI)
    Conventional Point Mutation Knockin

    A conventional point mutation mouse model is a knockin mouse line in which one or more nucleotides in the mouse genome are substituted by variant nucleotides. This can result in either an in-frame amino acid change within a given protein sequence, or a frameshift mutation. Knockin point mutation mouse models are widely used to study the roles of particular nucleotides or amino acids within proteins, which is directly applicable for studying human genetic diseases.

    Conventional Point Mutation Knockin
    Conditional Point Mutation Knockin

    A conditional point mutation mouse model introduces a point mutation when certain conditions are met. In the gene targeting strategy below, when Cre recombinase is present, a point mutation will be introduced tissue specifically via Cre activity. There are two major design strategies illustrated below.

    Conditional Point Mutation Knockin 2

    Traditional transgenic mouse models are generated via pronuclear injection of a plasmid, where many different founders can be obtained. Experimental results from different founders can vary and not be reproducible due to the differences in integration copy number and loci. Currently, most researchers use site-specific integration strategies to build gene edited mouse models. Rosa26 is the most commonly used “safe harbor” locus because Rosa26 encodes a nonessential nuclear RNA expressed in almost all tissues. Conditional expression of an exogenous gene will result when a LoxP-3XSTOP-LoxP sequence is inserted upstream of the exogenous sequence at the Rosa26 locus, and this model is crossed with a Cre deleter. Examples of additional safe harbor loci include H11 and TIGRE.

    Rosa26 Locus Knockin

    Genes tagged with EGFP, YFP, LacZ, Flag, mCherry and other sequences are useful for monitoring gene expression. Reporter gene mouse models are used to construct phylogenetic trees for cell development studies. Replacement of an endogenous gene with a reporter can simultaneously achieve gene knockout and knockin in the same mouse model.

    Tag & Reporter Gene

    The Tol2 mouse model allows generation of transgenic mice utilizing Tol2 transposase activity. The Tol2 transposon system not only can increase the gene integration rate, but also has the inclination to integrate foreign genes into AT rich regions.

    Tol2 Transgenic Mouse Model​
    Gene Editing by Technology
    Gene Editing by Technology
    CRISPR/EGE™-based Gene Editing
    Advantages & Disadvantages
    • High efficiency
    • Large gene knockout/knockin capabilities
    • Simultaneously targets multiple genes
    • Applicable to many species
    • Easy to construct
    • Off-target effects can be reduced by choosing the
    • Appropriate sgRNA and eliminated by breeding; southern blot is used to screen out random insertions
    Applications
    • Conventional KO mice/rats
    • Conditional KO mice/rats
    • ROSA26 locus gene KI mice/rats
    • Gene KI/ Mutation mice/rats
    • Humanized mice/rats
    • Reporter/KO-then-cKO mice/rats
    • Normal cell lines KO/KI
    • hESC/iPS cells KO/KI
    Timeline
    • 5-7 months
    See Details
    How Our Gene Editing Services Work

    How Our Gene Editing Services Work Biocytogen incorporates a bioinformatics approach to minimize off-target activity by searching the target genome for regions of similar sequence identity to the sgRNAs. Therefore, only sgRNAs with high specificity and high activity are chosen. As part of our quality control measures, we can perform 2 rounds of PCR to amplify the genomic regions around potential off-target sites, followed by sequencing to look for off-target events. We have also integrated Southern blot in our workflow as an important quality control step for generating knock-in and conditional knockout animal models to detect any potential random insertions. A dedicated project manager will be assigned to your project once it is initiated, they will provide monthly updates on the status of your model and are available to be reached at any time.

    How Our Gene Editing Services Work
    Case Studies

    For more detailed information about our gene editing service technologies, Download Gene Editing Brochure.

    case study 1
    Flvcr2 Conditional Knock-Out (cKO) and Reporter Knock-in (KI) by FLEx Strategy

    The Flvc2GFP allele was generated by homologous recombination in embryonic stem cells. Two sets of inverted loxP sites (one regular set and one mutated set) were introduced in order to remove the second exon and flip eGFP in-frame upon Cre recombination. Validation of the cloned construct by Southern blot was achieved using two probes and two restriction enzymes.

    Flvcr2 Conditional Knock-Out (cKO) and Reporter Knock-in (KI) by FLEx Strategy
    Frequently Asked Questions (FAQs)
    Q1: What is transgenic mice?
    Transgenic mice are genetically engineered laboratory animals that carry foreign genes deliberately inserted into their genome. These genetically modified mice are powerful tools in biomedical research, allowing scientists to study gene function, model human diseases, and evaluate potential therapeutic drugs in vivo.
    By introducing or modifying specific genes, researchers can create disease models for cancer, cardiovascular diseases, neurological disorders, and immunological conditions. Transgenic mouse models are widely used in preclinical studies, including drug discovery, gene therapy research, and toxicology testing, providing critical insights that are not possible with traditional animal models.
    The development of transgenic mice involves advanced gene editing technologies, such as CRISPR/Cas9, which ensure the precise insertion of target genes. As a result, these mice have become indispensable in pharmaceutical research, genetic studies, and precision medicine.
    Key Benefits of Transgenic Mice:
    • Accurate modeling of human genetic diseases
    • Testing drug efficacy and safety
    • Understanding gene function in vivo
    • Supporting biotechnology and pharmaceutical development